Search Results
Results found for "Dame Carol Robinson"
- GPCR Webinars | Dr. GPCR Ecosystem
Together in the Room Scientists from around the world, in the same conversation. If this is your first session, there's a lot more where this came from. Want to Go Deeper? session, the full recording becomes available on demand so scientists in every time zone can access the same
- GPCR Masterclass: Advanced Pharmacology & Drug Discovery | Dr. GPCR
What came as a pleasant surprise was how didactical and well-thought-out his course was—highly recommended
- Custom Molecules, Fluorescent Probes: When Chemists Think Like Biologists with Dr. Maria Majellaro from Celtarys | Dr. GPCR Ecosystem
When the time came to decide whether to leave the lab and lead Celtarys into biotech, she took the leap To date, she has successfully led seven funded projects.
- Univeristy Lecturers Details | Dr. GPCR Ecosystem
Your name and expertise remain at the heart of the course, continuing to inspire scientists long after You’ll be asked for: Instructor info – name, email, affiliation, short bio, photo, and optional social We’ll confirm your date together once your proposal is approved. 📝 Step 3: Prepare Your Content Create the technical and human challenges we encounter in our work GPCR researcher Contact Contact us First name * Last name Email* Write a message Submit
- Dr. Jennifer Pluznick: Olfactory Receptors in the Kidney and the Gut-Microbe Signal | Dr. GPCR Ecosystem
The name "olfactory receptor" narrows the imagination. Dr. Quotes "I famously said that I wasn't sure I could really trust the data because these crazy receptors came
- Dr. Terry Hébert | Dr. GPCR Ecosystem
journal clubs, daily Slack and Zoom contact, a faculty-vs-student trivia night — the lab's continuity came labs sharing a floor, shared equipment, and a public transit system that funnels everyone through the same
- Smells Like GPCR Spirit: Cracking Olfactory Codes with Alessandro Nicoli | Dr. GPCR Ecosystem
The Moment Chemistry Met Biology Nicoli’s turning point came when he realized that molecules weren’t
- Dr. Joseph Kim: Structural Biology and Drug Discovery at GPCRs | Dr. GPCR Ecosystem
Joseph Kim: My name is Joseph Kim. I go by Joe. Joseph Kim: It actually came from discussions with Ashish when I first joined the lab. The second “aha moment” came when I solved the structures of the μ-opioid and κ-opioid receptors bound
- Jacob Lee and Jin Cho: Rebuilding the Software Layer Under Modern Research | Dr. GPCR Ecosystem
Cho came from engineering software for military drones at General Atomics, and was stunned when he saw The GeneMode story starts with two teenagers in the same high-school classroom, different majors, different Although both went to the same college, Jacob and Jin choose different career paths.
- Dr. Aurélien Rizk | Dr. GPCR Ecosystem
Aurelien Rizk shared his journey of using these disciplines in biology and how his company, Interax, came
- Dr. Graciela Piñeyro: Partial Agonism, Receptor Recycling, and the Limits of Bias | Dr. GPCR Ecosystem
tolerance better than internalization itself Protean agonism and multiple active conformations — how the same Piñeyro watched the same ligand behave as an agonist under one condition and an inverse agonist under The resolution came not from a new experiment but from a model — protean agonism, as Kenakin had just THC's long-term effects on adolescent cognition sits alongside the analgesic one, and both require the same
- Dr. Paul Insel: Unbiased Discovery and the GPCRs We've Been Missing | Dr. GPCR Ecosystem
The biggest discoveries came from asking what was being overlooked Dr.
- GPCR Courses | Dr. GPCR Ecosystem
First name Last name Email* Join Our Mailing List Count me in! What came as a pleasant surprise was how didactical and well-thought-out his course was—highly recommended
- University | Dr. GPCR Ecosystem
What came as a pleasant surprise was how didactical and well-thought-out his course was—highly recommended hello@drgpcr.or(mailto:hello@drgpcr.com)g indicating how many people will register for the course, the names
- Dr. Tore Bengtsson: Rethinking β₂-Adrenergic Signaling in Metabolic Disease | Dr. GPCR Ecosystem
Bengtsson’s key scientific breakthroughs came from an unexpected experimental result: glucose uptake











